Biomarker may predict endometrial cancer recurrences
The deubiquitinating enzyme USP14 as a promising biomarker for identifying risk of recurrence in endometrial cancer patients, new research suggests.
The deubiquitinating enzyme USP14 as a promising biomarker for identifying risk of recurrence in endometrial cancer patients, new research suggests.
Leave a Reply